Sandoz’s Q4 2024 Results Show Strong Biosimilar Growth
Switzerland-headquartered Sandoz (SWX: SDZ) has released its Q4 2024 financial results. The firm’s global revenues...
Finanical Reports
Bayer Posts Steady Q4 Growth, Pharmaceutical Sales Lead the Way
German giant Bayer (ETR: BAYN) has released its Q4 2024 financial results, reporting a 0.7%...
Organon’s 2024 Financial Report Shows Steady Growth in Women’s Health and Biosimilars
Women’s health specialist Organon (NYSE: OGN) released its 2024 financial report, showing a 3% year-on-year...
BeiGene’s Q4 and 2024 Financials Highlight Significant Growth and Product Success
BeiGene, Ltd. (NASDAQ: ONC, HKG: 6160, SHA: 688235) released financial results and corporate updates from...
Zai Lab Q2 and Full-Year 2024 Report Shows Sales Growth and Loss Reduction
China-based biotech Zai Lab Ltd (NASDAQ: ZLAB, HKG: 9688) released its Q2 and full-year 2024...
Viatris Q4 and Full-Year Results Show Greater China Growth
US generics giant Viatris (NASDAQ: VTRS) released its Q4 and full-year 2024 financial results. In...
Dizal Pharma’s 2024 Revenues Surge 295% to RMB360M, Loss Narrows by RMB251M
China-based Dizal Pharmaceutical Co., Ltd (SHA: 688192) released its 2024 financial preview, showing annual revenues...
Ipsen Posts 8.7% Revenue Growth in 2024, Driven by Rare Diseases and Oncology
French biopharma firm Ipsen (EPA: IPN, OTCMKTS: IPSEY) reported an 8.7% year-on-year (YOY) increase in...
Baxter International Reports Q4 2024 Revenues of USD 2.75B, Up 2% YOY
Baxter International (NYSE: BAX) announced its fourth-quarter 2024 financial results, reporting revenues of USD 2.75...
AstraZeneca Faces Class Action Lawsuits Over China Legal Issues
AstraZeneca plc (AZ, NASDAQ: AZN) is facing multiple class action lawsuits in the United States...
Medtronic Q3 Earnings Show 4.1% Organic Growth, Driven by Cardiac Ablation
US-Irish medical device company Medtronic (NYSE: MDT) reported financial results for the third quarter (Q3)...
GE Healthcare Posts 1% Annual Revenue Growth in 2024 Financials
US medical device and life sciences giant GE Healthcare Technologies Inc. (NASDAQ: GEHC) released its...
Trinomab’s Antitetanus mAb Injection TNM002 Approved by NMPA
China-based Trinomab Biotech Co., Ltd has received market approval for its antitetanus toxin monoclonal antibody...
Gilead Sciences’ Q4 2024 Financials Show 6% Revenue Growth, Driven by HIV and Oncology
Gilead Sciences Inc. (NASDAQ: GILD) reported a 6% year-on-year (YOY) increase in global revenues for...
Siemens Healthineers Posts Strong Q1 Results with 5.7% Revenue Growth
Germany-based Siemens Healthineers AG (ETR: SHL) released its results for the first quarter of fiscal...
Bristol-Myers Squibb Posts 8% Q4 Revenue Growth, Driven by Opdivo and New Products
Bristol-Myers Squibb (BMS, NYSE: BMY) reported an 8% year-on-year (YOY) increase in revenues to USD...
Boston Scientific Posts Strong Q4 and Full-Year 2024 Results
Boston Scientific Corporation (NYSE: BSX) released its Q4 and full-year 2024 financial report, showing robust...
Regeneron’s Q4 Financials Show 10% Revenue Growth, Driven by Eylea and Libtayo
US-based biopharmaceutical company Regeneron (NASDAQ: REGN) released its Q4 2024 financial report, showing revenues up...
AstraZeneca’s 2024 Financials Beat Expectations with 21% Revenue Growth
UK-based pharmaceutical giant AstraZeneca (AZ, NASDAQ: AZN) reported total revenues of USD 54.07 billion in...
Eli Lilly’s Q4 Sales Soar 45% to $13.53B on Strength of GLP-1 Drugs
Eli Lilly & Co. (NYSE: LLY) reported a robust finish to 2024, with Q4 revenues...